Covariate-adjusted analysis of the Phase 3 REFLECT study of lenvatinib versus sorafenib in the treatment of unresectable hepatocellular carcinoma.

Both models show that the post-treatment anti-cancer variables are highly significant predictors of outcome.

also in 132,142 other papers

However, statistical testing of the imbalance results in a marginally insignificant difference between the groups in Table 1 ( p -values not reported).

also in 511 other papers